J
Judith Jaeger
Researcher at Johnson & Johnson
Publications - 8
Citations - 6517
Judith Jaeger is an academic researcher from Johnson & Johnson. The author has contributed to research in topics: Intravascular ultrasound & Restenosis. The author has an hindex of 7, co-authored 8 publications receiving 6413 citations.
Papers
More filters
Journal ArticleDOI
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.
Jeffrey W. Moses,Martin B. Leon,Jeffrey J. Popma,Peter J. Fitzgerald,David R. Holmes,Charles O'Shaughnessy,Ronald P. Caputo,Dean J. Kereiakes,David O. Williams,Paul S. Teirstein,Judith Jaeger,Richard E. Kuntz +11 more
TL;DR: In this randomized clinical trial involving patients with complex coronary lesions, the use of a sirolimus-eluting stent had a consistent treatment effect, reducing the rates of restenosis and associated clinical events in all subgroups analyzed.
Journal ArticleDOI
Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries: A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study
J. Eduardo Sousa,Marco A. Costa,Alexandre Abizaid,Andrea Abizaid,Fausto Feres,Ibraim Francisco Pinto,Ana C. Seixas,Rodolfo Staico,Luiz Alberto Mattos,Amanda G. M. R. Sousa,Robert Falotico,Judith Jaeger,Jeffrey J. Popma,Patrick W. Serruys +13 more
TL;DR: In this article, the safety and efficacy of sirolimus-coated BX Velocity stents were evaluated in 30 patients with angina pectoris electively treated with two different formulations of SIROlimuscoated stents (slow release and fast release).
Journal ArticleDOI
Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting Stents One-Year Angiographic and Intravascular Ultrasound Follow-Up
J. Eduardo Sousa,Marco A. Costa,Alexandre Abizaid,Benno J. Rensing,Andrea Abizaid,Luiz Fernando Tanajura,Ken Kozuma,Glenn Van Langenhove,Amanda G. M. R. Sousa,Robert Falotico,Judith Jaeger,Jeffrey J. Popma,Patrick W. Serruys +12 more
TL;DR: This study demonstrates a sustained suppression of neointimal proliferation by sirolimus-eluting Bx VELOCITY stents 1 year after implantation.
Journal ArticleDOI
Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries.
J. Eduardo Sousa,Marco A. Costa,Amanda G. M. R. Sousa,Alexandre Abizaid,Ana C. Seixas,Andrea Abizaid,Fausto Feres,Luiz Alberto Mattos,Robert Falotico,Judith Jaeger,Jeffrey J. Popma,Patrick W. Serruys +11 more
TL;DR: In-stent lumen dimensions remained essentially unchanged at 2-year follow-up in the 2 groups, although angiographic lumen loss was slightly higher in the FR group.
Journal ArticleDOI
Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study
J. Eduardo Sousa,Marco A. Costa,Alexandre Abizaid,Amanda G. M. R. Sousa,Fausto Feres,Luiz Alberto Mattos,Marinella Centemero,Galo Maldonado,Andrea Abizaid,Ibraim Pinto,Robert Falotico,Judith Jaeger,Jeffrey J. Popma,Patrick W. Serruys +13 more
TL;DR: This study demonstrates the safety and the potential utility of sirolimus-eluting Bx VELOCITY stents for the treatment of in-stent restenosis and shows no evidence of stent malapposition either acutely or in the follow-up IVUS images.